Change of auditor

RNS Number : 1341H

The MedicX Fund Limited

17 June 2013

 



For immediate release

17 June 2013

MedicX Fund Limited

Change of Auditor

The Board of MedicX Fund Limited (the "Company") announces the appointment of a new auditor.

Under its terms of reference the Audit Committee assesses annually the provision of any non-audit services by the auditor.  In view of the extent of non-audit services provided by the auditor during the previous financial year and in aggregate in recent years (primarily as a result of work relating to portfolio acquisitions), the Audit Committee considers it appropriate to separate the provision of audit and non-audit services. Further to the Audit Committee's recommendation, the Board has decided to appoint as auditor a firm that has not been involved in the provision of non-audit services.

Following a competitive tender process, KPMG LLP has agreed to accept appointment as the auditor to the Company.

PKF (UK) LLP has resigned as the Company's auditor and has confirmed to the Company that, in accordance with Section 273(2) of The Companies (Guernsey) Law 2008, there are no circumstances in connection with its resignation which it considers need to be brought to the attention of the members or creditors of the Company.

The Directors of the Company would like to thank PKF (UK) LLP for the service provided to the Company in the past.

- End -

For further information please contact:

MedicX Group                                                                            [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund Limited                                                                  [phone]

David Staples, Chairman

Buchanan                                                                                  [phone]

Charles Ryland/Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited (the "Company") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006.  It has committed investment of £443.7 million and a portfolio of 121 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group.  The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK. 

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCBRGDLUDBBGXL